{"id":987,"date":"2026-08-11T05:00:03","date_gmt":"2026-08-11T08:00:03","guid":{"rendered":"https:\/\/thaisromano.com.br\/blog\/manejo-nutricional-na-era-dos-agonistas-de-glp-1-o-que-devo-priorizar\/"},"modified":"2026-08-11T22:16:18","modified_gmt":"2026-08-12T01:16:18","slug":"manejo-nutricional-na-era-dos-agonistas-de-glp-1-o-que-devo-priorizar","status":"publish","type":"post","link":"https:\/\/thaisromano.com.br\/blog\/manejo-nutricional-na-era-dos-agonistas-de-glp-1-o-que-devo-priorizar\/","title":{"rendered":"Manejo nutricional na era dos agonistas de GLP-1: o que devo priorizar?"},"content":{"rendered":"<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_75 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title\" style=\"cursor:inherit\">Conte\u00fado<\/p>\n<p><span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Alternar tabela de conte\u00fado\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav>\n<ul class=\"ez-toc-list ez-toc-list-level-1 \">\n<li class=\"ez-toc-page-1 ez-toc-heading-level-2\"><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/nutritotal.com.br\/pro\/manejo-nutricional-na-era-dos-agonistas-de-glp-1-o-que-devo-priorizar\/#1_Prioridade_absoluta_preservacao_da_massa_magra_e_funcao_muscular\" target=\"_blank\" rel=\"noopener\">1. Prioridade absoluta: preserva\u00e7\u00e3o da massa magra e fun\u00e7\u00e3o muscular<\/a><\/li>\n<li class=\"ez-toc-page-1 ez-toc-heading-level-2\"><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/nutritotal.com.br\/pro\/manejo-nutricional-na-era-dos-agonistas-de-glp-1-o-que-devo-priorizar\/#2_Recomendacao_proteica_e_distribuicao_de_leucina\" target=\"_blank\" rel=\"noopener\">2. Recomenda\u00e7\u00e3o proteica e distribui\u00e7\u00e3o de leucina<\/a><\/li>\n<li class=\"ez-toc-page-1 ez-toc-heading-level-2\"><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/nutritotal.com.br\/pro\/manejo-nutricional-na-era-dos-agonistas-de-glp-1-o-que-devo-priorizar\/#3_Prioridade_no_manejo_de_sintomas_gastrointestinais_e_micronutrientes\" target=\"_blank\" rel=\"noopener\">3. Prioridade no manejo de sintomas gastrointestinais e micronutrientes<\/a>\n<ul class=\"ez-toc-list-level-3\">\n<li class=\"ez-toc-heading-level-3\"><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/nutritotal.com.br\/pro\/manejo-nutricional-na-era-dos-agonistas-de-glp-1-o-que-devo-priorizar\/#Tabela_de_Conduta_Nutricional_por_Perfil_de_Sintoma_Populacao\" target=\"_blank\" rel=\"noopener\">Tabela de Conduta Nutricional por Perfil de Sintoma \/ Popula\u00e7\u00e3o<\/a><\/li>\n<\/ul>\n<\/li>\n<li class=\"ez-toc-page-1 ez-toc-heading-level-2\"><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/nutritotal.com.br\/pro\/manejo-nutricional-na-era-dos-agonistas-de-glp-1-o-que-devo-priorizar\/#4_Aplicacao_pratica_no_consultorio\" target=\"_blank\" rel=\"noopener\">4. Aplica\u00e7\u00e3o pr\u00e1tica no consult\u00f3rio<\/a>\n<ul class=\"ez-toc-list-level-3\">\n<li class=\"ez-toc-heading-level-3\"><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/nutritotal.com.br\/pro\/manejo-nutricional-na-era-dos-agonistas-de-glp-1-o-que-devo-priorizar\/#Passo_1_Calculo_personalizado_da_meta_proteica\" target=\"_blank\" rel=\"noopener\">Passo 1: C\u00e1lculo personalizado da meta proteica<\/a><\/li>\n<li class=\"ez-toc-page-1 ez-toc-heading-level-3\"><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/nutritotal.com.br\/pro\/manejo-nutricional-na-era-dos-agonistas-de-glp-1-o-que-devo-priorizar\/#Passo_2_Avaliacao_de_composicao_corporal_e_forca_muscular\" target=\"_blank\" rel=\"noopener\">Passo 2: Avalia\u00e7\u00e3o de composi\u00e7\u00e3o corporal e for\u00e7a muscular<\/a><\/li>\n<li class=\"ez-toc-page-1 ez-toc-heading-level-3\"><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/nutritotal.com.br\/pro\/manejo-nutricional-na-era-dos-agonistas-de-glp-1-o-que-devo-priorizar\/#Passo_3_Ajuste_da_densidade_nutricional_e_suplementacao\" target=\"_blank\" rel=\"noopener\">Passo 3: Ajuste da densidade nutricional e suplementa\u00e7\u00e3o<\/a><\/li>\n<li class=\"ez-toc-page-1 ez-toc-heading-level-3\"><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/nutritotal.com.br\/pro\/manejo-nutricional-na-era-dos-agonistas-de-glp-1-o-que-devo-priorizar\/#Passo_4_Prescricao_do_exercicio_resistido\" target=\"_blank\" rel=\"noopener\">Passo 4: Prescri\u00e7\u00e3o do exerc\u00edcio resistido<\/a><\/li>\n<\/ul>\n<\/li>\n<li class=\"ez-toc-page-1 ez-toc-heading-level-2\"><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/nutritotal.com.br\/pro\/manejo-nutricional-na-era-dos-agonistas-de-glp-1-o-que-devo-priorizar\/#5_Conclusao\" target=\"_blank\" rel=\"noopener\">5. Conclus\u00e3o<\/a><\/li>\n<li class=\"ez-toc-page-1 ez-toc-heading-level-2\"><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/nutritotal.com.br\/pro\/manejo-nutricional-na-era-dos-agonistas-de-glp-1-o-que-devo-priorizar\/#Quer_saber_mais\" target=\"_blank\" rel=\"noopener\">Quer saber mais?<\/a><\/li>\n<li class=\"ez-toc-page-1 ez-toc-heading-level-2\"><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/nutritotal.com.br\/pro\/manejo-nutricional-na-era-dos-agonistas-de-glp-1-o-que-devo-priorizar\/#Referencias\" target=\"_blank\" rel=\"noopener\">Refer\u00eancias<\/a><\/li>\n<\/ul>\n<\/nav>\n<\/div>\n<p>A ascens\u00e3o dos agonistas do receptor do pept\u00eddeo semelhante ao glucagon-1 (GLP-1RAs), exemplificados pela semaglutida, e dos agonistas receptores duplos GIP\/GLP-1, como a tirzepatida, redefiniu o manejo cl\u00ednico da obesidade e das doen\u00e7as cardiometab\u00f3licas.<\/p>\n<p>A nova Diretriz Brasileira de Tratamento Farmacol\u00f3gico da Obesidade da ABESO (2026) e o Algoritmo da AACE (2025) refor\u00e7am que a medica\u00e7\u00e3o \u00e9 uma ferramenta adjuvante de alta efic\u00e1cia, mas que exige, obrigatoriamente, o acompanhamento nutricional cont\u00ednuo.<\/p>\n<div id=\"attachment_66105\" style=\"width: 1160px\" class=\"wp-caption alignleft\"><img loading=\"lazy\" decoding=\"async\" loading=\"lazy\" aria-describedby=\"caption-attachment-66105\" class=\"wp-image-989 size-full\" src=\"https:\/\/thaisromano.com.br\/blog\/wp-content\/uploads\/2026\/08\/portal-para-nutricionistas-agonistas-de-glp-1-manejo-nutricional.webp\" alt=\"Agonistas de GLP-1 manejo nutricional\" width=\"1150\" height=\"460\" srcset=\"https:\/\/thaisromano.com.br\/blog\/wp-content\/uploads\/2026\/08\/portal-para-nutricionistas-agonistas-de-glp-1-manejo-nutricional.webp 1150w, https:\/\/thaisromano.com.br\/blog\/wp-content\/uploads\/2026\/08\/portal-para-nutricionistas-agonistas-de-glp-1-manejo-nutricional-300x120.webp 300w, https:\/\/thaisromano.com.br\/blog\/wp-content\/uploads\/2026\/08\/portal-para-nutricionistas-agonistas-de-glp-1-manejo-nutricional-1024x410.webp 1024w, https:\/\/thaisromano.com.br\/blog\/wp-content\/uploads\/2026\/08\/portal-para-nutricionistas-agonistas-de-glp-1-manejo-nutricional-768x307.webp 768w\" sizes=\"auto, (max-width: 1150px) 100vw, 1150px\" \/><\/p>\n<p id=\"caption-attachment-66105\" class=\"wp-caption-text\">Fonte: Canva<\/p>\n<\/div>\n<p>Ao retardarem o esvaziamento g\u00e1strico e promoverem saciedade central via a\u00e7\u00e3o hipotal\u00e2mica, esses f\u00e1rmacos induzem uma redu\u00e7\u00e3o volunt\u00e1ria da ingest\u00e3o cal\u00f3rica que pode variar de 15% a 30% nas fases iniciais. Diante desse cen\u00e1rio de profunda restri\u00e7\u00e3o alimentar <em>ad libitum<\/em>, a pergunta central para o nutricionista cl\u00ednico \u00e9: <strong>em meio a tantas mudan\u00e7as fisiol\u00f3gicas, o que priorizar na conduta nutricional?<\/strong><\/p>\n<h2><span class=\"ez-toc-section\" id=\"1_Prioridade_absoluta_preservacao_da_massa_magra_e_funcao_muscular\"><\/span>1. Prioridade absoluta: preserva\u00e7\u00e3o da massa magra e fun\u00e7\u00e3o muscular<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Embora a perda de peso promovida pelos agonistas de GLP-1 e GIP\/GLP-1 seja composta predominantemente por tecido adiposo, subestudos de composi\u00e7\u00e3o corporal por DXA (como os do programa STEP com semaglutida e SURMOUNT-1 com tirzepatida) revelam que cerca de <strong>20% a 25% do peso perdido pode corresponder \u00e0 massa magra<\/strong> (m\u00fasculo esquel\u00e9tico, v\u00edsceras e \u00e1gua corporal).<\/p>\n<p>A diminui\u00e7\u00e3o desenfreada da massa isenta de gordura reduz a taxa metab\u00f3lica de repouso (TMR), compromete a for\u00e7a funcional e eleva o risco de obesidade sarcop\u00eanica \u2014 especialmente em idosos ou indiv\u00edduos sedent\u00e1rios.<\/p>\n<p>\u250c\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2510\u2502\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Desafio na Terapia com GLP-1\/GIP\u2514\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u252c\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2518\u2502\u25bcRedu\u00e7\u00e3o Acentuada do Apetite e TMR\u2502\u250c\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2534\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2510\u25bc\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 \u25bcPerda de Massa Gorda\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Perda de Massa Magra(~75-80%)\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 (~20-25%)\u2502\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 \u2502\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 \u250c\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2534\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2510\u2502\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 \u25bc\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 \u25bc\u2502\u00a0\u00a0\u00a0\u00a0 Queda na For\u00e7a\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Redu\u00e7\u00e3o da Taxa\u2502\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Funcional\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Metab\u00f3lica (TMR)\u2502\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 \u2502\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 \u2502\u2514\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u253c\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2518\u25bcManejo Nutricional Focado:Prote\u00edna + Treino de For\u00e7a (RT)<\/p>\n<p>Para conter o catabolismo proteico, a literatura preconiza utilizar o <strong>Peso Corporal Ajustado (AjBW)<\/strong> para o c\u00e1lculo das necessidades em pacientes com obesidade, evitando o hiperdimensionamento:<\/p>\n<p><strong>AjBW= Peso Ideal + 0,25 x (Peso Atual &#8211; Peso Ideal)<\/strong><\/p>\n<h2><span class=\"ez-toc-section\" id=\"2_Recomendacao_proteica_e_distribuicao_de_leucina\"><\/span>2. Recomenda\u00e7\u00e3o proteica e distribui\u00e7\u00e3o de leucina<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>As diretrizes recentes da ESPEN (2026) e o Consenso EASO\/EFAD\/ECPO publicado no <em>Lancet Diabetes &amp; Endocrinology<\/em> (2026) estabelecem metas claras para a adequa\u00e7\u00e3o do consumo de prote\u00ednas em adultos em uso de terapias incret\u00ednicas:<\/p>\n<ul>\n<li><strong>Meta di\u00e1ria:<\/strong> Prescrever de 1,2 a 1,6 g\/kg AjBW\/dia para adultos e idosos.<\/li>\n<li><strong>Fracionamento por refei\u00e7\u00e3o:<\/strong> Garantir de 0,3 a 0,4 g\/kg\/refei\u00e7\u00e3o distribu\u00eddos em 3 a 4 refei\u00e7\u00f5es ao longo do dia.<\/li>\n<li><strong>Limiar anab\u00f3lico de leucina:<\/strong> Cada refei\u00e7\u00e3o principal deve conter entre 2,5 e 3,0g<strong> de leucina<\/strong> para ativar a sinaliza\u00e7\u00e3o da via mTORC1 no tecido muscular, superando eventual resist\u00eancia anab\u00f3lica.<\/li>\n<li><strong>Estrat\u00e9gia de <em>&#8220;Front-Loading&#8221;<\/em>:<\/strong> Como a saciedade e o empachamento g\u00e1strico tendem a se acumular ao longo do dia, priorizar o maior aporte proteico na primeira refei\u00e7\u00e3o (desjejum) apresenta excelente ades\u00e3o cl\u00ednica.<\/li>\n<\/ul>\n<h2><span class=\"ez-toc-section\" id=\"3_Prioridade_no_manejo_de_sintomas_gastrointestinais_e_micronutrientes\"><\/span>3. Prioridade no manejo de sintomas gastrointestinais e micronutrientes<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>A ades\u00e3o ao tratamento e a garantia de densidade nutricional dependem do controle dos efeitos adversos gastrointestinais comuns (n\u00e1useas, v\u00f4mitos, empachamento, obstipa\u00e7\u00e3o).<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Tabela_de_Conduta_Nutricional_por_Perfil_de_Sintoma_Populacao\"><\/span>Tabela de Conduta Nutricional por Perfil de Sintoma \/ Popula\u00e7\u00e3o<span class=\"ez-toc-section-end\"><\/span><\/h3>\n<table>\n<thead>\n<tr>\n<td><strong>Condi\u00e7\u00e3o \/ Perfil Cl\u00ednico<\/strong><\/td>\n<td><strong>Prioridade de Conduta Nutricional<\/strong><\/td>\n<td><strong>Estrat\u00e9gia de Prescri\u00e7\u00e3o \/ Suplementa\u00e7\u00e3o<\/strong><\/td>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td><strong>N\u00e1useas e Empachamento<\/strong><\/td>\n<td>Volume reduzido e densidade proteica<\/td>\n<td>Refei\u00e7\u00f5es fracionadas, textura macia\/pastosa, evitar l\u00edquidos junto \u00e0s refei\u00e7\u00f5es e prepara\u00e7\u00f5es gordurosas.<\/td>\n<\/tr>\n<tr>\n<td><strong>Anorexia Acentuada \/ Inapet\u00eancia<\/strong><\/td>\n<td>Suplementa\u00e7\u00e3o proteica precoce<\/td>\n<td>M\u00f3dulos de Whey Protein, prote\u00edna vegetal isolada ou Amino\u00e1cidos Essenciais (EAA); suplementos orais de baixo volume.<\/td>\n<\/tr>\n<tr>\n<td><strong>Constipa\u00e7\u00e3o Intestinal<\/strong><\/td>\n<td>Modula\u00e7\u00e3o de fibra e hidrata\u00e7\u00e3o<\/td>\n<td>Aporte h\u00eddrico fracionado 30\u201335mL\/kg; fibras sol\u00faveis de baixa fermenta\u00e7\u00e3o (psyllium, goma guar parcial\/hidrolisada).<\/td>\n<\/tr>\n<tr>\n<td><strong>Risco de car\u00eancias de micronutrientes<\/strong><\/td>\n<td>Rastreio e Reposi\u00e7\u00e3o Direcionada<\/td>\n<td>Monitoramento de Vitamina D, B12, ferro e zinco. Suplementa\u00e7\u00e3o multivitam\u00ednica\/mineral se ingest\u00e3o &lt;1.200 kcal\/dia.<\/td>\n<\/tr>\n<tr>\n<td><strong>V\u00f4mitos Persistentes \/ Recorrentes<\/strong><\/td>\n<td><strong>Preven\u00e7\u00e3o de Encefalopatia de Wernicke<\/strong><\/td>\n<td><strong>Suplementa\u00e7\u00e3o urgente de Tiamina (Vitamina B1)<\/strong> antes da reposi\u00e7\u00e3o de carboidratos em quadros de desnutri\u00e7\u00e3o.<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2><\/h2>\n<h2><span class=\"ez-toc-section\" id=\"4_Aplicacao_pratica_no_consultorio\"><\/span>4. Aplica\u00e7\u00e3o pr\u00e1tica no consult\u00f3rio<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Para estruturar a conduta do nutricionista de forma eficiente e alinhada \u00e0s evid\u00eancias, aplique o seguinte fluxo de tomada de decis\u00e3o:<\/p>\n<p>\u250c\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2510\u2502\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Fluxo de Aplica\u00e7\u00e3o Pr\u00e1tica no Consult\u00f3rio\u00a0\u00a0\u00a0\u00a0\u00a0 \u2502\u2514\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2518\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 \u00a0\u2502\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u250c\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2534\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2510\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u25bc\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u25bc\u00a0 PASSO 1: C\u00e1lculo Metab\u00f3lico\u00a0\u00a0 \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 PASSO 2: Avalia\u00e7\u00e3o Funcional\u00a0\u00a0 Definir AjBW e meta de\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 \u00a0Dinamometria + BIA\/DXA\u00a0\u00a0 1,2 a 1,6 g\/kg\/dia\u00a0\u00a0 \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 (Baseline e Acompanhamento)\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 \u2502\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 \u2502\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 \u2514\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500&#8212;-\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2518\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 \u00a0\u00a0\u2502\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 \u00a0\u25bc\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 \u00a0PASSO 3: Divis\u00e3o Proteica\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 \u00a00,3 a 0,4 g\/kg por refei\u00e7\u00e3o\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 \u00a0(2,5 a 3,0 g de Leucina\/ref)\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u2502\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 \u250c\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500&#8212;\u2500\u2500\u2500\u2510\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 \u25bc\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u25bc\u00a0 Sintomas GI Ausentes\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 \u00a0Sintomas GI Presentes\u00a0 &#8211; Fontes alimentares \u00edntegras \u00a0\u00a0\u00a0\u00a0 &#8211; Estrat\u00e9gia &#8220;Front-loading&#8221;\u00a0\u00a0\u00a0 (ovos, aves, peixes, tofu)\u00a0 \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 &#8211; Suplementa\u00e7\u00e3o proteica em p\u00f3\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 &#8211; Ajuste de textura e fibras\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 \u00a0\u00a0\u2502\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 \u00a0\u25bc\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 \u00a0\u00a0\u00a0\u00a0 PASSO 4: Est\u00edmulo resistido\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Treino de For\u00e7a (2 a 3x\/semana)<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Passo_1_Calculo_personalizado_da_meta_proteica\"><\/span>Passo 1: C\u00e1lculo personalizado da meta proteica<span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Calcule o Peso Ajustado (AjBW) do paciente e fixe a meta proteica entre 1,2 e 1,6g\/kg AjBW\/dia. Em casos de idosos ou pacientes com sarcopenia diagnosticada, trabalhe na faixa superior dessa recomenda\u00e7\u00e3o.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Passo_2_Avaliacao_de_composicao_corporal_e_forca_muscular\"><\/span>Passo 2: Avalia\u00e7\u00e3o de composi\u00e7\u00e3o corporal e for\u00e7a muscular<span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Acompanhe o paciente a cada <strong>8 a 12 semanas<\/strong> atrav\u00e9s de Bioimped\u00e2ncia El\u00e9trica (BIA) ou DXA. Utilize a <strong>dinamometria de preens\u00e3o manual<\/strong> na consulta inicial para monitorar a for\u00e7a funcional ao longo da perda ponderal.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Passo_3_Ajuste_da_densidade_nutricional_e_suplementacao\"><\/span>Passo 3: Ajuste da densidade nutricional e suplementa\u00e7\u00e3o<span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Se a Ingest\u00e3o Cal\u00f3rica Total estiver abaixo das necessidades basais e o paciente n\u00e3o atingir a cota de prote\u00edna via alimenta\u00e7\u00e3o s\u00f3lida, prescreva precocemente suplementos em p\u00f3 (Whey Protein isolado\/hidrolisado, prote\u00ednas vegetais) ou f\u00f3rmulas de amino\u00e1cidos essenciais (EAA) fracionadas ao longo do dia.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Passo_4_Prescricao_do_exercicio_resistido\"><\/span>Passo 4: Prescri\u00e7\u00e3o do exerc\u00edcio resistido<span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Alinhe com a equipe multidisciplinar ou educador f\u00edsico a obrigatoriedade da pr\u00e1tica de <strong>Treinamento Resistido (Muscula\u00e7\u00e3o)<\/strong> de 2 a 3 vezes por semana. O est\u00edmulo mec\u00e2nico do exerc\u00edcio de for\u00e7a \u00e9 o principal fator sin\u00e9rgico com a dieta hiperproteica para sinalizar a s\u00edntese proteica muscular e evitar a sarcopenia induzida pelo r\u00e1pido emagrecimento.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"5_Conclusao\"><\/span>5. Conclus\u00e3o<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Em suma, \u00e9 importante termos em mente que a consolida\u00e7\u00e3o dos agonistas de GLP-1 e terapias combinadas na rotina cl\u00ednica n\u00e3o anula o papel do nutricionista; pelo contr\u00e1rio, redefine e eleva a import\u00e2ncia da interven\u00e7\u00e3o nutricional personalizada. Diante de uma perda de peso acelerada e de uma saciedade quimicamente induzida, a conduta no consult\u00f3rio deve migrar da simples gera\u00e7\u00e3o de d\u00e9ficit cal\u00f3rico para a gest\u00e3o ativa da densidade nutricional, preserva\u00e7\u00e3o da massa magra e preven\u00e7\u00e3o de car\u00eancias metab\u00f3licas. Ao priorizar o c\u00e1lculo pelo peso ajustado, a distribui\u00e7\u00e3o estrat\u00e9gica de leucina, o rastreio rigoroso de micronutrientes e a ades\u00e3o ao treino de for\u00e7a, o profissional assegura que o emagrecimento do paciente seja acompanhado de sa\u00fade muscular, funcionalidade e sustentabilidade dos resultados a longo prazo.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Quer_saber_mais\"><\/span>Quer saber mais?<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>\ud83d\udc49 <strong><a href=\"https:\/\/conteudo.nutritotal.com.br\/pesquisa-novas-mudancas-nutritotal\" target=\"_blank\" rel=\"noopener\">CLIQUE AQUI E BAIXE UM EBOOK EXCLUSIVO<\/a><\/strong><\/p>\n<h2><span class=\"ez-toc-section\" id=\"Referencias\"><\/span>Refer\u00eancias<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>ARSLAN, Sedat. Medical nutrition in the glucagon-like peptide-1 (GLP-1) era: Protein strategies, micronutrient monitoring, and lean mass preservation. <strong>Clinical Nutrition ESPEN<\/strong>, [S. l.], v. 73, p. 103305, 2026.<\/p>\n<p>DOBBIE, Laurence et al. Nutritional, functional, and psychological considerations for incretin-based therapies in adults\u2014an EASO, EFAD, and ECPO Consensus Statement. <strong>The Lancet Diabetes &amp; Endocrinology<\/strong>, [S. l.], v. 14, n. 8, p. 612-628, 2026.<\/p>\n<p>NADOLSKY, Karl et al. American Association of Clinical Endocrinology Consensus Statement: Algorithm for the Evaluation and Treatment of Adults with Obesity\/Adiposity-Based Chronic Disease &#8211; 2025 Update. <strong>Endocrine Practice<\/strong>, [S. l.], v. 31, n. 11, p. 1351-1394, 2025.<\/p>\n<p>ASSOCIA\u00c7\u00c3O BRASILEIRA PARA O ESTUDO DA OBESIDADE E S\u00cdNDROME METAB\u00d3LICA (ABESO). <strong>Diretriz Brasileira de Tratamento Farmacol\u00f3gico da Obesidade<\/strong>. S\u00e3o Paulo: ABESO, 2026.<\/p>\n<p>NEELAND, Ian J.; LINGE, Jennifer; BIRKENFELD, Andreas L. Changes in lean body mass with glucagon-like peptide-1-based therapies and mitigation strategies. <strong>Diabetes, Obesity and Metabolism<\/strong>, [S. l.], v. 26, n. 1, p. 16-27, 2024.<\/p>\n<p>JASTREBOFF, Ania M. et al. Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1). <strong>The New England Journal of Medicine<\/strong>, [S. l.], v. 387, n. 3, p. 205-216, 2022.<\/p>\n<p>WILDING, John P. H. et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1). <strong>The New England Journal of Medicine<\/strong>, [S. l.], v. 384, n. 11, p. 998-1009, 2021.<\/p>\n<p class=\"fonte-original\"><em>Fonte: <a href=\"https:\/\/nutritotal.com.br\/pro\/manejo-nutricional-na-era-dos-agonistas-de-glp-1-o-que-devo-priorizar\/\" target=\"_blank\" rel=\"nofollow noopener\">nutritotal.com.br<\/a><\/em><\/p>\n","protected":false},"excerpt":{"rendered":"<p>A ascens\u00e3o dos agonistas do receptor do pept\u00eddeo semelhante ao glucagon-1 (GLP-1RAs), exemplificados pela semaglutida, e dos agonistas receptores duplos GIP\/GLP-1, como a tirzepatida, redefiniu o manejo cl\u00ednico da obesidade e das doen\u00e7as cardiometab\u00f3licas. A nova Diretriz Brasileira de Tratamento Farmacol\u00f3gico da Obesidade da ABESO (2026) e o Algoritmo da AACE (2025) refor\u00e7am que a [&hellip;]<\/p>\n","protected":false},"author":0,"featured_media":988,"comment_status":"open","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[111],"tags":[],"class_list":["post-987","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-na-midia"],"_links":{"self":[{"href":"https:\/\/thaisromano.com.br\/blog\/wp-json\/wp\/v2\/posts\/987","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/thaisromano.com.br\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/thaisromano.com.br\/blog\/wp-json\/wp\/v2\/types\/post"}],"replies":[{"embeddable":true,"href":"https:\/\/thaisromano.com.br\/blog\/wp-json\/wp\/v2\/comments?post=987"}],"version-history":[{"count":1,"href":"https:\/\/thaisromano.com.br\/blog\/wp-json\/wp\/v2\/posts\/987\/revisions"}],"predecessor-version":[{"id":990,"href":"https:\/\/thaisromano.com.br\/blog\/wp-json\/wp\/v2\/posts\/987\/revisions\/990"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/thaisromano.com.br\/blog\/wp-json\/wp\/v2\/media\/988"}],"wp:attachment":[{"href":"https:\/\/thaisromano.com.br\/blog\/wp-json\/wp\/v2\/media?parent=987"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/thaisromano.com.br\/blog\/wp-json\/wp\/v2\/categories?post=987"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/thaisromano.com.br\/blog\/wp-json\/wp\/v2\/tags?post=987"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}